Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
Christoph Rosak,1 Gabriele Mertes21Specialist for Internal Medicine, Endocrinology and Diabetes, Sachsenhausen Hospital, Frankfurt/Main, Germany; 2Retired, Mülheim, GermanyAbstract: The alpha-glucosidase inhibitor acarbose has been used for more than 20 years in the management of hyperg...
Enregistré dans:
Auteurs principaux: | Rosak C, Mertes G |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f256b809ffb548318d75dd940d72f69e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco
par: Shihabi AR, et autres
Publié: (2013) -
Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
par: Uy J, et autres
Publié: (2012) -
Treating the elderly diabetic patient: special considerations
par: Kezerle L, et autres
Publié: (2014) -
Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
par: Maffioli P, et autres
Publié: (2011) -
Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
par: Hoimark L, et autres
Publié: (2012)